Tag: fda

Israel’s DiA gets $14M to expand AI-driven ultrasound analysis

Israel-based AI healthtech company, DiA Imaging Analysis, which is using deep learning and machine learning to automate analysis of ultrasound scans, has closed a $14 million Series B round of funding. Backers in the growth round, which comes three years after DiA last raised, include new investors Alchimia Ventures, Downing…

Read More

This startup just created a fast, accurate COVID test that only needs saliva and links to an app

We’re entering a phase in the COVID-19 pandemic where transmission is going to go through the roof because of the Delta variant. But as vaccinations ramp up around the world, the main cost to society now will not be the health services being overwhelmed, but mass disruption to businesses as…

Read More

As clinical guidelines shift, heart disease screening startup pulls in $43M Series B

Cleerly Coronary, a company that uses A.I powered imaging to analyze heart scans, announced a $43 million Series B funding this week. The funding comes at a moment when it seems that a new way of screening for heart disease is on its way.  Cleerly was started in 2017 by…

Read More

Johnson & Johnson’s COVID-19 vaccine is 85% effective against severe cases, and 66% effective overall per trial data

Another COVID-19 vaccine is almost ready to begin being distributed – a single-shot inoculation made by Johnson & Johnson’s Janssen pharmaceutical subsidiary. The company just released an efficacy report based on data from its Phase 3 trial, which found that the new vaccine is 66% effective overall in preventing moderate…

Read More

LabCorp COVID-19 test kit has just been approved for sale over-the-counter

LabCorp has now become the first company to receive approval to sell its COVID-19 test kit over-the-counter without a prescription, according to a statement from the company. One of the largest diagnostics testing companies in the U.S., LabCorp could be a significant competitor to companies like EverlyWell, which received approvals…

Read More

AstraZeneca says it will likely do another study of COVID-19 vaccine after accidental lower dose shows higher efficacy

AstraZeneca’s CEO told Bloomberg that the pharmaceutical company will likely conduct another global trial of the effectiveness of its COVID-19 vaccine trial, following the disclosure that the more effective dosage in the existing Phase 3 clinical trial was actually administered by accident. AstraZeneca and its partner the University of Oxford…

Read More